Metabolic effects of fluoxetine in adults with type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trials.
BACKGROUND: The prevalence of obesity and diabetes is increasing dramatically throughout the world. Studies have shown that excess adiposity is a critical predictor of new onset T2DM. This meta-analysis is aimed to assess the metabolic effects of fluoxetine in T2DM. METHODS AND FINDINGS: Electronic...
Main Authors: | Zi Ye, Lili Chen, Zhen Yang, Qin Li, Ying Huang, Min He, Shuo Zhang, Zhaoyun Zhang, Xuanchun Wang, Weiwei Zhao, Ji Hu, Chao Liu, Shen Qu, Renming Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3145630?pdf=render |
Similar Items
-
Lipocalin-2, glucose metabolism and chronic low-grade systemic inflammation in Chinese people
by: Huang Ying, et al.
Published: (2012-01-01) -
Insulin resistance in Chinese patients with type 2 diabetes is associated with C-reactive protein independent of abdominal obesity
by: Feng Xiaocheng, et al.
Published: (2010-12-01) -
The efficacy of Crocus sativus (Saffron) versus placebo and Fluoxetine in treating depression: a systematic review and meta-analysis
by: Khaksarian M, et al.
Published: (2019-04-01) -
Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes
by: Zhang Zhaoyun, et al.
Published: (2011-08-01) -
Role of fluoxetine in pharmacological enhancement of motor functions in stroke patients: A randomized, placebo-controlled, single-blind trial
by: Karthickeyan Krishnan, et al.
Published: (2021-09-01)